9/10/18

The Rock Weekly

End of an era

As digital health funding soared higher than ever, its most rotten apple yet is shutting down: Theranos will be no more. Before things unraveled, Holmes’ enterprise was an apparent poster child for innovation. Its demise is a reminder of the cautious approach required by startups in healthcare, echoed last week by 22-year Apple veteran Robin Goldstein—and by security expert Bruce Schneier who warns about technology innovation at large.

Headlines

For Safety’s Sake, We Must Slow Innovation In Internet-Connected Things
"Strict liability laws chill innovation—but that’s what’s needed right now" Technology Review

Bye, Theranos.
Its efforts are now focused on avoiding bankruptcy The New York Times

How Sutter Health Is Enabling A Human Experience Through Innovation And Tech Partnerships
Sutter knows healthcare can be hard for startups. So they're taking an interdisciplinary approach. Rock Health

23andMe Cuts Off The DNA App Ecosystem It Created
They’re also eyeing a $749 "premium" service for deeper health data Wired

If AI Is Going To Be The World’s Doctor, It Needs Better Textbooks
After talking to doctors and patients, what wasn't apparent to computer scientists becomes evident Quartz

Anti-Aging Medicine Is So Hot Even This Controversial Idea Has Investors
Harvard spinout asks, "What if aging didn’t have to suck?" It's the latest "young blood" initiative Technology Review

Recent Funding

×